A protein complex expressed during terminal differentiation of monomyelocytic cells is an inhibitor of cell growth |
| |
Authors: | S Murao F Collart E Huberman |
| |
Institution: | Biological and Medical Research Division, Argonne National Laboratory, Illinois 60439. |
| |
Abstract: | A protein complex (PC) composed of the MRP8 and MRP14 proteins has previously been shown to be a specific inhibitor of casein kinase I and II. This PC is expressed during the late stages of terminal differentiation induced in human promyelocytic HL-60 leukemia cells by 1 alpha,25-dihydroxyvitamin D3 and in human monocytic THP-1 leukemia cells by phorbol 12-myristate 13-acetate. This expression is associated with terminal cell differentiation because incubation of HL-60 cells with an agent or condition that causes suppression of growth but not induction of differentiation does not result in expression of the PC. At concentrations of 5-15 nM, the purified PC inhibited the growth of HL-60 cells and THP-1 cells, as well as other cell types belonging to different cell lineages. This growth inhibition was preceded by a reduction in 32P]phosphate incorporation and, at the higher PC concentrations, was associated with a reduction in 3H]thymidine, 3H]uridine, and 32S]methionine incorporation. The specific expression pattern and growth-inhibitory character of the PC suggests that the complex may have a role in suppressing cell growth during monomyelocytic terminal differentiation induced by specific chemical stimuli and during physiological and pathological events associated with monomyelocytic cell functions. |
| |
Keywords: | |
|
|